Aion Therapeutic Financials
ANTCF Stock | USD 0.03 0.02 185.71% |
Aion |
Understanding current and past Aion Therapeutic Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aion Therapeutic's financial statements are interrelated, with each one affecting the others. For example, an increase in Aion Therapeutic's assets may result in an increase in income on the income statement.
Aion Therapeutic Stock Summary
Aion Therapeutic competes with Genomma Lab. Aion Therapeutic Inc., a pharmaceutical company, offer medical cannabis products in Canada. Aion Therapeutic Inc. was incorporated in 2011 and is headquartered in Toronto, Canada. Aion Therapeutic is traded on OTC Exchange in the United States.Instrument | USA Pink Sheet View All |
Exchange | PINK Exchange |
Business Address | 45 Sheppard Avenue |
Sector | Healthcare |
Industry | Drug Manufacturers—Specialty & Generic |
Benchmark | Dow Jones Industrial |
Website | www.aiontherapeutic.com |
Phone | 416 460 3000 |
Currency | USD - US Dollar |
Aion Therapeutic Key Financial Ratios
There are many critical financial ratios that Aion Therapeutic's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Aion Therapeutic reports annually and quarterly.Return On Equity | -4.17 | |||
Return On Asset | -0.96 | |||
Beta | 0.29 | |||
Z Score | -78.0 |
Aion Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aion Therapeutic's current stock value. Our valuation model uses many indicators to compare Aion Therapeutic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aion Therapeutic competition to find correlations between indicators driving Aion Therapeutic's intrinsic value. More Info.Aion Therapeutic is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aion Therapeutic's earnings, one of the primary drivers of an investment's value.Aion Therapeutic Systematic Risk
Aion Therapeutic's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aion Therapeutic volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Aion Therapeutic correlated with the market. If Beta is less than 0 Aion Therapeutic generally moves in the opposite direction as compared to the market. If Aion Therapeutic Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aion Therapeutic is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aion Therapeutic is generally in the same direction as the market. If Beta > 1 Aion Therapeutic moves generally in the same direction as, but more than the movement of the benchmark.
Aion Therapeutic December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Aion Therapeutic help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aion Therapeutic. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aion Therapeutic based on widely used predictive technical indicators. In general, we focus on analyzing Aion Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aion Therapeutic's daily price indicators and compare them against related drivers.
Information Ratio | 0.19 | |||
Maximum Drawdown | 451.8 | |||
Value At Risk | (48.53) | |||
Potential Upside | 84.21 |
Complementary Tools for Aion Pink Sheet analysis
When running Aion Therapeutic's price analysis, check to measure Aion Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aion Therapeutic is operating at the current time. Most of Aion Therapeutic's value examination focuses on studying past and present price action to predict the probability of Aion Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aion Therapeutic's price. Additionally, you may evaluate how the addition of Aion Therapeutic to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |